ibd and glp 1 Could GLP-1s be used as an adjunctive or co-therapy to treat IBD? There's some compelling data as well as clinical trials in the works! GLP-1 Medications: Reimagining the Treatment

In the PD Drosophila model, overexpression of Nrf2 and knockdown of Keap1 alleviate the decline in locomotor ability (170)

It sits on the standard formulary, PA requirements are straightforward, and your copay applies

For independent background, see the PubChem entry for Melanotan II

By increasing the activity or number of L-cells producing GLP-1, this approach can potentially improve therapeutic outcomes, reduce reliance on synthetic agonists, and minimize associated side effects

Hadidchi and her team are committed to supporting you at every step, helping you set realistic goals and answering any questions you may have about your progress or potential side effects